US 11,873,280 B2
Cross-linking agent(s)
Musa Alhakimi, Oakville (CA); Gamil Alhakimi, Oakville (CA); and Lisa Studnicki, Oakville (CA)
Assigned to GL CHEMTEC VISION INC., Oakville (CA)
Filed by GL CHEMTEC VISION INC., Oakville (CA)
Filed on Jan. 7, 2021, as Appl. No. 17/143,297.
Application 17/143,297 is a continuation of application No. 16/323,818, granted, now 10,919,853, previously published as PCT/CA2017/050933, filed on Aug. 4, 2017.
Claims priority of provisional application 62/372,537, filed on Aug. 9, 2016.
Prior Publication US 2021/0130292 A1, May 6, 2021
This patent is subject to a terminal disclaimer.
Int. Cl. C07D 207/277 (2006.01); G02C 7/04 (2006.01); A61L 27/52 (2006.01); A61L 27/18 (2006.01); C08F 220/26 (2006.01); C08F 220/34 (2006.01); C08K 5/3415 (2006.01); G02B 1/04 (2006.01); C08F 220/28 (2006.01); C08F 220/38 (2006.01)
CPC C07D 207/277 (2013.01) [A61L 27/18 (2013.01); A61L 27/52 (2013.01); C08F 220/26 (2013.01); C08F 220/34 (2013.01); C08K 5/3415 (2013.01); G02B 1/043 (2013.01); G02C 7/04 (2013.01); A61L 2430/16 (2013.01); C08F 220/283 (2020.02); C08F 220/382 (2020.02); C08F 2800/20 (2013.01)] 47 Claims
 
1. A compound of formula I:

OG Complex Work Unit Chemistry
R1-R11 are the same or different, and are each independently selected from H, halo, hydroxyl, a substituted or unsubstituted hydrocarbon group, a substituted or unsubstituted heterogeneous group, a substituted or unsubstituted carbocyclic group, a substituted or unsubstituted heterocyclic group, a substituted or unsubstituted aromatic group, a substituted or unsubstituted heteroaromatic group, or NRaRb, wherein Ra and Rb are the same or different, and are independently selected from H, halo, hydroxyl, amino, a substituted or unsubstituted hydrocarbon group, a substituted or unsubstituted heterogeneous group, a substituted or unsubstituted carbocyclic group, a substituted or unsubstituted heterocyclic group, a substituted or unsubstituted aromatic group, or a substituted or unsubstituted heteroaromatic group;
X1 is selected from NRa, NRaC(O), OC(O)NRa, NRaC(O)O, NRaC(O)NH, NHC(O)NRa, OC(O), NHC(O)NHZ0—NH—C(O)NH, OC(O)NHZ0—NH—C(O)O, OC(O)NHZ0—NH—C(O)NH, or NHC(O)NHZ0—NH—C(O)O; where Z0 is a linear or branched C2-C12 alkylene divalent radical, or a C5-C7 cycloaliphatic divalent radical, each of which can optionally include one or more linkages of O, NRa and C(O);
X2 is selected from a direct bond, a heteroatom, C(O), a substituted or unsubstituted hydrocarbon group, a substituted or unsubstituted heterogeneous group, a substituted or unsubstituted carbocyclic group, a substituted or unsubstituted heterocyclic group, a substituted or unsubstituted aromatic group, a substituted or unsubstituted heteroaromatic group, or NRa; and
Z is selected from a heteroatom, C(O), a substituted or unsubstituted hydrocarbon group, a substituted or unsubstituted heterogeneous group, a substituted or unsubstituted carbocyclic group, a substituted or unsubstituted heterocyclic group, a substituted or unsubstituted aromatic group, a substituted or unsubstituted heteroaromatic group, NRa, or [SiR12R13O]wSiR12R13, wherein R12 and R13 are the same or different, and are independently selected from H, halo, hydroxyl, amino, a substituted or unsubstituted hydrocarbon group, a substituted or unsubstituted heterogeneous group, a substituted or unsubstituted carbocyclic group, a substituted or unsubstituted heterocyclic group, a substituted or unsubstituted aromatic group, or a substituted or unsubstituted heteroaromatic group, and w is from 0 to 60.